A tumor-targeting near-infrared laser-triggered drug delivery system based on GO@Ag nanoparticles for chemo-photothermal therapy and X-ray imaging

Biomaterials

Volumn 35, Issue 22, 2014, Pages 5847-5861

  Shi, Jinjin ^a   Wang, Lei ^a   Zhang, Jing ^a   Ma, Rou ^a   Gao, Jun ^a   Liu, Yan ^a   Zhang, Chaofeng ^a   Zhang, Zhenzhong ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Controlled drug release; GO@Ag; Tumor targeting; X ray imaging

Indexed keywords

CHEMICAL STABILITY; CHEMOTHERAPY; DIAGNOSIS; DISEASES; DRUG DELIVERY; DRUG PRODUCTS; INFRARED DEVICES; NANOPARTICLES; PHYSIOLOGICAL MODELS; SYNTHESIS (CHEMICAL); TUMORS; X RAY ANALYSIS;

CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; NEAR-INFRARED LASERS; PHOTOTHERMAL ABLATION; PHYSIOLOGICAL SOLUTION; TUMOR-TARGETING; X-RAY CONTRAST AGENTS; XRAY IMAGING;

SILVER;

CONTRAST MEDIUM; DOXORUBICIN; DRUG CARRIER; ESTER; GRAPHENE OXIDE; MACROGOL 2000; SILVER; SILVER NANOPARTICLE; SILVER NITRATE; TRIPEPTIDE; 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE-N-METHOXY-POLY(ETHYLENE GLYCOL 2000); ANTINEOPLASTIC ANTIBIOTIC; GRAPHITE; MACROGOL DERIVATIVE; NANOPARTICLE; OXIDE; PHOSPHATIDYLETHANOLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER DIAGNOSIS; CHEMICAL BOND; CHEMICAL REACTION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOTOXICITY; DIAGNOSTIC VALUE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG STABILITY; DRUG TARGETING; DRUG UPTAKE; FEMALE; HIGH TEMPERATURE; HUMAN; HUMAN CELL; IN VIVO STUDY; INFRARED SPECTROSCOPY; LASER; MOUSE; NANOFABRICATION; NEAR INFRARED LASER; NONHUMAN; PHOTOCHEMOTHERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; RADIOGRAPHY; SURFACE PLASMON RESONANCE; TUMOR ABLATION; ANIMAL; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; DRUG SCREENING; HYPERTHERMIC THERAPY; NEOPLASMS; PATHOLOGY; PHOTOTHERAPY; PROCEDURES; TUMOR CELL LINE;

MURINAE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; DOXORUBICIN; DRUG DELIVERY SYSTEMS; GRAPHITE; HUMANS; HYPERTHERMIA, INDUCED; LASERS; MICE; NANOPARTICLES; NEOPLASMS; OXIDES; PHOSPHATIDYLETHANOLAMINES; PHOTOTHERAPY; POLYETHYLENE GLYCOLS; SILVER; TOMOGRAPHY, X-RAY COMPUTED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84899973696     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.03.042     Document Type: Article

References (58)

1. Langer R. Drug delivery and targeting. Nature 1998, 392:5-10.
2. Matsumura Y., Maeda H. Anew concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986, 46:6387-6392.
3. Moghimi S.M., Hunter A.C., Murray J.C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001, 53:283-318.
4. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2:751-760.
5. Moghimi S.M., Hunter A.C., Murray J.C. Nanomedicine: current status and future prospects. FASEB J 2005, 19:311-330.
6. Youns M, Hoheisel JD, Efferth T. Therapeutic and diagnostic applications of nanoparticles. Curr Drug Targets.12:357-365.
7. Cohen-Karni T., Langer R., Kohane D.S. The smartest materials: the future of nanoelectronics in medicine. ACS Nano 2012, 6:6541-6545.
8. Duan X., Xiao J., Yin Q., Zhang Z., Yu H., Mao S., et al. Smart pH-Sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram. ACS Nano 2013, 7:5858-5869.
9. McCoy C.P., Brady C., Cowley J.F., McGlinchey S.M., McGoldrick N., Kinnear D.J., et al. Triggered drug delivery from biomaterials. Expert Opin Drug Deliv 2010, 7:605-616.
10. Chen C., Zhou L., Geng J., Ren J., Qu X. Photosensitizer-incorporated quadruplex DNA-gated nanovechicles for light-triggered, targeted dual drug delivery to cancer cells. Small 2013, 9:2793-2800.
11. Brown P.K., Qureshi A.T., Moll A.N., Hayes D.J., Monroe W.T. Silver nanoscale antisense drug delivery system for photoactivated gene silencing. ACS Nano 2013, 7:2948-2959.
12. Luo L., Guo Y., Yang J., Liu Y., Chu S., Kong F., et al. An efficient visible light controlled protein delivery system. Chem Commun (Camb) 2011, 47:11243-11245.
13. McCoy C.P., Rooney C., Edwards C.R., Jones D.S., Gorman S.P. Light-triggered molecule-scale drug dosing devices. JAm Chem Soc 2007, 129:9572-9573.
14. Chen J., Guo Z., Wang H.B., Gong M., Kong X.K., Xia P., et al. Multifunctional Fe3O4@C@Ag hybrid nanoparticles as dual modal imaging probes and near-infrared light-responsive drug delivery platform. Biomaterials 2013, 34:571-581.
15. Nahum E., Skippen P.W., Gagnon R.E., Macnab A.J., Skarsgard E.D. Correlation of transcutaneous hepatic near-infrared spectroscopy readings with liver surface readings and perfusion parameters in a piglet endotoxemic shock model. Liver Int 2006, 26:1277-1282.
16. Weissleder R. Aclearer vision for invivo imaging. Nat Biotechnol 2001, 19:316-317.
17. Polizzi M.A., Stasko N.A., Schoenfisch M.H. Water-soluble nitric oxide-releasing gold nanoparticles. Langmuir 2007, 23:4938-4943.
18. Hong R., Han G., Fernandez J.M., Kim B.J., Forbes N.S., Rotello V.M. Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. JAm Chem Soc 2006, 128:1078-1079.
19. Lee S.E., Liu G.L., Kim F., Lee L.P. Remote optical switch for localized and selective control of gene interference. Nano Lett 2009, 9:562-570.
20. Li JL., Day D., Gu M. Ultra-low energy threshold for cancer photothermal therapy using transferrin-conjugated gold nanorods. Adv Mater 2008, 20:3866-3871.
21. Novoselov K.S., Jiang Z., Zhang Y., Morozov S.V., Stormer H.L., Zeitler U., et al. Room-temperature quantum hall effect in graphene. Science 2007, 315:1379.
22. Zhang Y., Tan Y.W., Stormer H.L., Kim P. Experimental observation of the quantum hall effect and Berry's phase in graphene. Nature 2005, 438:201-204.
23. Balandin A.A., Ghosh S., Bao W., Calizo I., Teweldebrhan D., Miao F., et al. Superior thermal conductivity of single-layer graphene. Nano Lett 2008, 8:902-907.
24. Lee C., Wei X., Kysar J.W., Hone J. Measurement of the elastic properties and intrinsic strength of monolayer graphene. Science 2008, 321:385-388.
25. Bao H., Pan Y., Ping Y., Sahoo N.G., Wu T., Li L., et al. Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. Small 2011, 7:1569-1578.
26. Liu Z., Robinson J.T., Sun X., Dai H. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. JAm Chem Soc 2008, 130:10876-10877.
27. He Q., Sudibya H.G., Yin Z., Wu S., Li H., Boey F., et al. Centimeter-long and large-scale micropatterns of reduced graphene oxide films: fabrication and sensing applications. ACS Nano 2010, 4:3201-3208.
28. Sudibya H.G., He Q., Zhang H., Chen P. Electrical detection of metal ions using field-effect transistors based on micropatterned reduced graphene oxide films. ACS Nano 2011, 5:1990-1994.
29. Zhang W., Guo Z., Huang D., Liu Z., Guo X., Zhong H. Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide. Biomaterials 2011, 32:8555-8561.
30. Whitby R.L., Korobeinyk A., Gun'ko V.M., Busquets R., Cundy A.B., Laszlo K., et al. pH-driven physicochemical conformational changes of single-layer graphene oxide. Chem Commun (Camb) 2011, 47:9645-9647.
31. An J., Gou Y., Yang C., Hu F., Wang C. Synthesis of a biocompatible gelatin functionalized graphene nanosheets and its application for drug delivery. Mater Sci Eng C Mater Biol Appl 2013, 33:2827-2837.
32. Reid P.E., Brown N.J., Holen I. Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact. Mol Cancer 2009, 8:49.
33. Baar J., Silverman P., Lyons J., Fu P., Abdul-Karim F., Ziats N., et al. Avasculature-targeting regimen of preoperative docetaxel with or without bevacizumab for locally advanced breast cancer: impact on angiogenic biomarkers. Clin Cancer Res 2009, 15:3583-3590.
34. Pasqualini R., Koivunen E., Kain R., Lahdenranta J., Sakamoto M., Stryhn A., et al. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res 2000, 60:722-727.
35. Oostendorp M., Douma K., Hackeng T.M., van Zandvoort M.A., Post M.J., Backes W.H. Pharmacokinetics of contrast agents targeted to the tumor vasculature in molecular magnetic resonance imaging. Contrast Media Mol Imaging 2010, 5:9-17.
36. Luan Y., Xu W. The structure and main functions of aminopeptidase N. Curr Med Chem 2007, 14:639-647.
37. Zhang Z., Wang B., Li H., Zhou T., Zhang L. The inhibitory effects of nanosize delivery system for antisense oligonucleotide of hTERT on EC9706 cells. Cancer Biol Ther 2007, 6:329-334.
38. Colombo G., Curnis F., De Mori G.M., Gasparri A., Longoni C., Sacchi A., et al. Structure-activity relationships of linear and cyclic peptides containing the NGR tumor-homing motif. JBiol Chem 2002, 277:47891-47897.
39. Pastorino F., Brignole C., Marimpietri D., Cilli M., Gambini C., Ribatti D., et al. Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy. Cancer Res 2003, 63:7400-7409.
40. Garde S.V., Forte A.J., Ge M., Lepekhin E.A., Panchal C.J., Rabbani S.A., et al. Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects. Anticancer Drugs 2007, 18:1189-1200.
41. Pinteala M., Dascalu A., Ungurenasu C. Binding fullerenol C(60)(OH)(24) to dsDNA. Int J Nanomedicine 2009, 4:193-199.
42. Huang X., El-Sayed I.H., Qian W., El-Sayed M.A. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. JAm Chem Soc 2006, 128:2115-2120.
43. Chen J., Wang D., Xi J., Au L., Siekkinen A., Warsen A., et al. Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells. Nano Lett 2007, 7:1318-1322.
44. Sur I., Cam D., Kahraman M., Baysal A., Culha M. Interaction of multi-functional silver nanoparticles with living cells. Nanotechnology 2010, 21:175104.
45. Ravindran A., Chandran P., Khan S.S. Biofunctionalized silver nanoparticles: advances and prospects. Colloids Surf B Biointerfaces 2013, 105:342-352.
46. Moon H.K., Lee S.H., Choi H.C. Invivo near-infrared mediated tumor destruction by photothermal effect of carbon nanotubes. ACS Nano 2009, 3:3707-3713.
47. Liu X., Tao H., Yang K., Zhang S., Lee S.T., Liu Z. Optimization of surface chemistry on single-walled carbon nanotubes for invivo photothermal ablation of tumors. Biomaterials 2011, 32:144-151.
48. Yang K., Wan J., Zhang S., Tian B., Zhang Y., Liu Z. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials 2012, 33:2206-2214.
49. Rai P., Mallidi S., Zheng X., Rahmanzadeh R., Mir Y., Elrington S., et al. Development and applications of photo-triggered theranostic agents. Adv Drug Deliv Rev 2010, 62:1094-1124.
50. Liu H., Shen M., Zhao J., Zhu J., Xiao T., Cao X., et al. Facile formation of folic acid-modified dendrimer-stabilized gold-silver alloy nanoparticles for potential cellular computed tomography imaging applications. Analyst 2013, 138:1979-1987.
51. Wang L., Shi J., Zhang H., Li H., Gao Y., Wang Z., et al. Synergistic anticancer effect of RNAi and photothermal therapy mediated by functionalized single-walled carbon nanotubes. Biomaterials 2013, 34:262-274.
52. Jiang J.G.H., Shao H., Devlin E., Papaefthymiou G.C., Ying J.Y. Bifunctional Fe3O4-Ag heterodimer nanoparticles for two-photonfluorescence imaging and magnetic manipulation. Adv Mater 2008, 20:4403-4407.
53. Skirtach A.G., Antipov A.A., Shchukin D.G., Sukhorukov G.B. Remote activation of capsules containing Ag nanoparticles and IR dye by laser light. Langmuir 2004, 20:6988-6992.
54. Liu Z., Sun X., Nakayama-Ratchford N., Dai H. Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. ACS Nano 2007, 1:50-56.
55. Murakami T., Ajima K., Miyawaki J., Yudasaka M., Iijima S., Shiba K. Drug-loaded carbon nanohorns: adsorption and release of dexamethasone invitro. Mol Pharm 2004, 1:399-405.
56. Godet C.D.D., Sabbah H., Ababou-Girard S., Solal F. Bulk and surface plasmon excitations in amorphous carbon measured by core-level photoelectron spectroscopy. Appl Surf Sci 2009, 255:6598-6606.
57. Wang L., Shi J., Jia X., Liu R., Wang H., Wang Z., et al. NIR-/pH-Responsive drug delivery of functionalized single-walled carbon nanotubes for potential application in cancer chemo-photothermal therapy. Pharm Res 2013, 30:2757-2771.
58. Shi J., Liu Y., Wang L., Gao J., Zhang J., Yu X., et al. Atumoral acidic pH-responsive drug delivery system based on a novel photosensitizer (fullerene) for invitro and invivo chemo-photodynamic therapy. Acta Biomater 2014, 10:1280-1291.